Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spreadNewsletter archive Search issue 51 - Spring 2025 Find out how our scientists are developing improved breast cancer ...

Turning cancer’s weakness into a weapon: 20 years of PARP inhibitors and BRCA researchThe goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, ...

Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spreadA collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously ...

Turning cancer’s weakness into a weapon: 20 years of PARP inhibitors and BRCA researchNewsletter archive Search issue 51 - Spring 2025 Find out how our scientists are developing improved breast cancer ...

Turning cancer’s weakness into a weapon: 20 years of PARP inhibitors and BRCA researchTwo decades ago, a pivotal exchange between two scientists sparked a scientific and medical revolution. Professor ...

Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatmentThe goal of our laboratory is to improve the treatment and survival of ...

Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting ...

Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective ...

‘Every day is valuable’— Sally’s melanoma storySally in her garden. Credit: John Angerson Sally Steadman-South, a mother of two from Sheffield, was diagnosed with melanoma in 2014 at the age of 34, ...